???global.info.a_carregar???
Marta Pojo. Concluiu o(a) Doutoramento em PhD Program in Health Sciences em 2016 pelo(a) Universidade do Minho Escola de Medicina, Mestrado em Mestrado em Biotecnologia e Bio-Empreendedorismo em Plantas aromáticas e Medicinais em 2010/03/18 pelo(a) Universidade do Minho Escola de Ciências e Licenciatura em Biologia Aplicada em 2007 pelo(a) Universidade do Minho Escola de Ciências. É Investigador no(a) Liga Portuguesa Contra o Cancro e Investigador no(a) Instituto Português de Oncologia de Lisboa Francisco Gentil EPE. Publicou 11 artigos em revistas especializadas. Possui 3 capítulo(s) de livros. Organizou 4 evento(s). Orientou 4 dissertação(ões) de mestrado e coorientou 1. Orientou 2 trabalho(s) de conclusão de curso de licenciatura/bacharelato. Recebeu 8 prémio(s) e/ou homenagens. Participa e/ou participou como Bolseiro de Investigação em 1 projeto(s), Investigador em 4 projeto(s) e Investigador responsável em 1 projeto(s). Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Ciências da Saúde. Nas suas atividades profissionais interagiu com 90 colaborador(es) em coautorias de trabalhos científicos. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Glioma; Molecular pathology; Prognostic biomarkers; 615.322; 576.3; 577.1; biomarker; glioblastoma; oncogene; prognosis; WNT6; WNT pathway; Ciências Médicas::Medicina Básica; Science & Technology; HOXA9; Transcriptome; GBM; Microarrays; R/bioconductor; Dendrimers; Drug delivery systems; Glioblastoma; Intracellular; Nanoparticles; Prognosis; Oncogene; Temozolomide; HOTAIR; Monocarboxylate transporters (MCTs); Tumor hypoxia; Lactate; Glioblastomas; Warburg effect; "brain tumours"; "Melanoma"; "Therapy resistance"; .
Read full resume ↓
Identification

Personal identification

Full name
Marta Pojo

Citation names

  • Pojo, Marta

Author identifiers

Ciência ID
D419-C66C-69AE
ORCID iD
0000-0002-4036-6731
Scopus Author Id
Marta Pojo

Knowledge fields

  • Medical and Health Sciences - Health Sciences

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
Education
Degree Classification
2016/04/11 - 2016/04/15
Concluded
 Curso em Epidemiologia e Bioestatística Aplicada à Investigação em Saúde (Outros)
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2016
Concluded
 PhD Program in Health Sciences (Doutoramento)
Universidade do Minho Escola de Medicina, Portugal
"HOXA9 as a key regulator in glioma initiation, aggressiveness and response to therapy" (THESIS/DISSERTATION)
 Approved with unanimously and top honors
2010/03/18
Concluded
 Mestrado em Biotecnologia e Bio-Empreendedorismo em Plantas aromáticas e Medicinais (Mestrado)
Major in Biotecnologia
Universidade do Minho Escola de Ciências, Portugal
"COMPOSTOS NATURAIS EXTRAÍDOS DE PLANTAS NA PROTECÇÃO DO STRESSE OXIDATIVO EM MODELOS CELULARES DE MÚSCULO" (THESIS/DISSERTATION)
 17
2007
Concluded
 Biologia Aplicada (Licenciatura)
Universidade do Minho Escola de Ciências, Portugal
"BIOLOGIA APLICADA" (THESIS/DISSERTATION)
 14
Affiliation

Science

Category
Host institution 		Employer
2016/01/18 - Current Researcher (Research) Liga Portuguesa Contra o Cancro, Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
2016/01/18 - Current Researcher (Research) Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Positions / Appointments

Category
Host institution 		Employer
2021/02/01 - Current Organic Unit Director Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal
Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal

Others

Category
Host institution 		Employer
2012/01/01 - 2015/12/31 PhD FCT fellow Fundação para a Ciência e a Tecnologia, Portugal
Universidade do Minho, Portugal
2011/06/01 - 2011/12/31 Research fellowship Fundação para a Ciência e a Tecnologia, Portugal
Universidade do Minho, Portugal
Projects

Grant

Designation Funders
2020/04/04 - 2022/04/30 Immune microenvironment in melanoma: clinical impact of regulatory T cells and tumor-associated macrophages in prognosis and response to therapy
Grant Terry Fox 2020/2020
Researcher
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
 Liga Portuguesa Contra o Cancro Núcleo Regional do Sul
Ongoing
2018/04/30 - 2020/04/30 PIK3CA functional mutation in gliomas: clinical impact and pharmacological inhibition
Terry Fox Grant 2018-2020
Researcher
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
 Liga Portuguesa Contra o Cancro Núcleo Regional do Sul
Ongoing
2018/02/04 - 2020/01/31 The effect of somatropin therapy in residual pediatric CNS tumors in children who developed growth hormone deficiency
SPEDM Grant (grant Drª Maria da Conceição Barbas 2018
Researcher
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
 Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo
Ongoing
2019/01/01 - 2019/10/31 iNOVA4Health - Programme in Translational Medicine (iBET, CEDOC/FCM, IPOLFG and ITQB)
UID/Multi/04462/2019
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal

Universidade Nova de Lisboa, Portugal

Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal

Universidade Nova de Lisboa Medical School, Portugal

Instituto de Biologia Experimental e Tecnológica, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2017/03/01 - 2019/03/31 The role of Tumour-associated Macrophages (TAMs) in Anaplastic Thyroid Cancer Aggressiveness
Merck 2017
Researcher
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
 Merck & Co Inc
Ongoing
2011/06/01 - 2011/12/31 The Transcriptome of the Oncogenic HOXA9 Homeoprotein in Human Glioblastoma: Characterization and Functional Significance.
PTDC/SAU-GMG/113795/2009
Research Fellow
Universidade do Minho, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded

Contract

Designation Funders
2023/09/01 - Current Life Sciences for a Healthy and Sustainable Future
LA/P/0087/2020
10.54499/LA/P/0087/2020
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Universidade Nova de Lisboa Molecular Structural and Cellular Microbiology, Portugal

Universidade Nova de Lisboa, Portugal

Instituto de Biologia Experimental e Tecnológica, Portugal

Instituto Gulbenkian de Ciência, Portugal

Universidade de Lisboa Centro de Estudos Comparatistas, Portugal

BioResources 4 Sustainability, Portugal

Universidade de Trás-os-Montes e Alto Douro Centro de Investigação e de Tecnologias Agro-Ambientais e Biologicas, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2021/01/01 - 2025/12/31 ICVS/3B¿s - Laboratório Associado, Instituto de Ciências da Vida e da Saúde / Grupo de Investigação em Biomateriais, Biodegradaveis e Biomiméticos
LA/P/0050/2020
10.54499/LA/P/0050/2020
UID/Multi/50026/2019
Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2022 - 2023 New opportunities for small molecules in immuno-oncology
EXPL/MED-QUI/1316/2021
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2017/11/01 - 2019/12/30 The Effect of Olive Oil Compounds in the Prevention of UV-Induced Melanomagenesis
LISBOA-01-0145-FEDER-007344
Principal investigator
iNOVA4Health, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2014/01/01 - 2016/01/01 Surface-Engineered Dendrimers as Novel Nanocarriers for the Delivery of Temozolomide Chemotherapy into Malignant Brain Tumors”
ICVS/3B’s – Associate Laboratory
Researcher
Laboratório Associado ICVS 3B's, Portugal
Cancelled
Outputs

Publications

Book chapter
  1. Luís, R.; Brito, C.; Pojo, M.. "Melanoma Metabolism: Cell Survival and Resistance to Therapy". 203-223. 2020.
    10.1007/978-3-030-34025-4_11
  2. S., Celine; Lourenco, Tatiana; Xavier-Magalhaes, Ana; Pojo, Marta; M., Bruno. "Mechanisms of Aggressiveness in Glioblastoma: Prognostic and Potential Therapeutic Insights". In Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications. InTech, 2013.
    10.5772/52361
  3. Pojo, Marta; Marques, Bruno. "Molecular Hallmarks of Gliomas". In Molecular Targets of CNS Tumors. Portugal: InTech, 2011.
    10.5772/21352
Conference abstract
  1. Pires, Carolina; Lainé, Hugo; Ehlers, Anna C.; Saramago, Ana; Moura, Margarida; Pojo, Marta; Cabrera, Rafael; et al. "MULTIOMICS APPROACH REVEALS ALTERATIONS UNDERLYING PAEDIATRIC THYROID CANCER RISK AND AGGRESSIVENESS". Paper presented in Congresso Português de Endocrinologia - 75ª Reunião Anual da SPEDM, Vilamoura, 2024.
    Published
  2. Pires, Carolina; Lainé, Hugo; Ehlers, Anna C.; Saramago, Ana; Moura, Margarida; Pojo, Marta; Cabrera, Rafael; et al. "Multiomics approach reveals alterations underlying paedriatic thyroid cancer risk and aggressiveness". Paper presented in Congresso Português de Endocrinologia 2024 - 75ª Reunião Anual da SPEDM, Vilamoura, 2024.
    Published
  3. Ricardo Rodrigues; Ana Pinto; Marta Pojo; Diana Pacheco Sousa; Ana Sofia Carvalho; Hans C. Beck; Matthiesen, Rune; et al. "SPRY4 COMO POTENCIAL MEDIADOR DO PAPEL ANTI-TUMORAL DOS MACRÓFAGOS NO CARCINOMA ANAPLÁSICO DA TIRÓIDE". Paper presented in 74ª Reunião Anual da Sociedade Portuguesa de Endocrinologia Diabetes, Vilamoura, 2023.
    Published
  4. Rodrigues, Ricardo; Pinto, Ana Teresa; Pojo, Marta; Pacheco, Diana Sousa; Carvalho, Ana Sofia; Beck, Hans C.; Matthiesen, Rune; Pires, Carolina; et al.. "SPRY4 como potencial mediador do papel anti-tumoral dos macrófagos no carcinoma anaplásico da tiroide". Paper presented in Congresso Português de Endocrinologia - 74ª Reunião Anual da SPEDM, Vilamoura, 2023.
    Published
  5. Acúrcio, Rita C; Pozzi, Sabina; Carreira, Bárbara; Pojo, Marta; Casemiro, Sandra; Leandro, Paula; Fernandes, Adelaide; et al. "Immune Checkpoint Blockade by Novel Small-Molecule Inhibitors Restores T Cell Function". Paper presented in 1st Spring Virtual Meeting on Medicinal Chemistry, 2021.
    Published • 10.3390/chemproc2021004001
  6. Gonçalves, Céline S.; Pojo, Marta; Costa, Bruno M.. "Regulation of WNT signaling by HOXA9 in glioblastoma: mechanistic, prognostic and therapeutic insights". Paper presented in SPSAS – Advances in Molecular Oncology: Translating Molecular Biology into Cancer Treatment, São Paulo, 2013.
Conference paper
  1. Pojo, Marta. "Evaluation of PIK3CA mutational status in glioma molecular subgroups". Paper presented in European Association of Neuro-Oncology meeting, Leon, 2019.
    DOI: 10.1093/neuonc/noz126.094
  2. Pojo, Marta; Gonçalves, Céline S.; Xavier-Magalhães, Ana; Oliveira, Ana Isabel; Costa, Sandra Maria Araújo da; Pinto, Luísa; Reis, R. M.; et al. "HOXA9 promotes glioblastoma initiation, aggressiveness and resistance to therapy". 2014.
Conference poster
  1. Tomás, Ana; Maximino, José; Nunes, Hugo; Salvador, Rute; Luís, Rafael; Brito, Cheila; Diana P Saraiva; et al. "Identifying potential predictive and prognostic biomarkers in cutaneous melanoma". Paper presented in 1st NMS Research Week, 2023.
  2. Tomás, Ana; José Maximino; Hugo Nunes; Rafael Luís; Cheila Brito; Diana P Saraiva; Salvador, Rute; et al. "Identifying potential predictive and prognostic immune biomarkers in cutaneous melanoma". Paper presented in 1st NMS Research Week, 2023.
  3. Tomás, Ana; José Maximino; Hugo Nunes; Salvador, Rute; Vitor Farricha; Elisabete Lopez Carvalho; Patrícia Pereira; et al. "Clinical impact of CCR4high regulatory T cells and polarized monocytes in cutaneous melanoma". Paper presented in EACR 2023, 2023.
  4. Cristina Demelas; Escrevente, Cristina; Barral, Duarte C.; Pojo, Marta; Serpa, Jacinta. "Role of melanosome exocytosis in cutaneous melanoma invasion and response to immunotherapy". 2023.
  5. Rodrigues, Ricardo; Pinto, Ana; Pojo, Marta; Pacheco, Diana; Carvalho, A. S.; Beck, H. C.; Matthiesen, Rune; et al. "The dual role of tumour-associated macrophages in anaplastic thyroid cancer.". Paper presented in 5th ASPIC International Congress, 2022.
  6. Tomás, Ana; Maximino, José; Nunes, Hugo; Salvador, Rute; Luís, Rafael; Brito, Cheila; Diana P Saraiva; et al. "CCR4 high regulatory T cells and polarized monocytes as potential circulating biomarkers in cutaneous melanoma prognosis". Paper presented in 5th ASPIC International Congress, 2022.
  7. Saraiva, Inês; Chaves, Pedro; Brito, Cheila; Tomás, Ana; Maximino, José; Ferreira, Andreia; Farricha, Victor; et al. "Understanding the mechanism of ARL1 and ARL15 in the aggressiveness of cutaneous melanoma". Paper presented in 5th ASPIC International Congress, 2022.
  8. Martins, Eduarda P.; Gonçalves, Céline S.; Pojo, Marta; Carvalho, Rita; Ribeiro, Ana S; Vera Miranda-Gonçalves; Taipa, Ricardo; et al. "Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma". Paper presented in 11th Brain Tumor Meeting 2022, 2022.
  9. Tomás, Ana; Maximino, José; Nunes, Hugo; Salvador, Rute; Luís, Rafael; Brito, Cheila; Diana P Saraiva; et al. "Uncovering the immune profile of advanced cutaneous melanoma". Paper presented in XLVII Meeting of the Portuguese Society for Immunology, 2022.
  10. Simões-Pereira, Joana; Saramago, Ana; Rodrigues, Ricardo; Pojo, Marta; Pires, Carolina; Horta, Mariana; López-Presa, D.; et al. "Factores preditivos da resposta/avidez ao iodo nos carcinomas papilares da tiróide metastáticos.". Paper presented in Congresso Português de Endocrinologia - 73ª Reunião Anual da SPEDM, 2022.
  11. Hipólito, Ana; Brito, Cheila; Tomás, Ana; Vicente, João B; Pojo, Marta; Serpa, Jacinta. "MST and EAAT3 are key players in the metabolic reliance on cysteine in BRD9-c.183G>C melanoma cells". Paper presented in Cutaneous Melanoma: From Where to Where, 2021.
  12. Brito, Cheila; Ferreira, Renato; Pojo, Marta; Fragoso, Sofia; Santos, Sidónia; Silva, José Miguel. "BRD9 as a novel susceptibility gene for familial cutaneous melanoma". Paper presented in Cutaneous melanoma: From where to where?, 2021.
  13. Tomás, Ana; Maximino, José; Nunes, Hugo; Luís, Rafael; Brito, Cheila; Saraiva, Diana; Salvador, Rute; et al. "Immune profiling in cutaneous melanoma: a prognostic and predictive tool". Paper presented in Cutaneous Melanoma: From Where to Where, 2021.
  14. Tomás, Ana; Brito, Cheila; Azevedo, Ana; Esteves, Susana; Mafra, Manuela; Roque, Lúcia; Pojo, Marta. "PIK3CA activating mutations: from clinical impact in glioma molecular subgroups to targeted inhibition in glioma cell models". Paper presented in Cancer Biology: From Basic to Translational Research, LPCC-NRS, Webinar, 2020.
  15. Martins, Eduarda P.; Gonçalves, Céline S.; Pojo, Marta; Carvalho, Rita; Ribeiro, Ana S.; Taipa, Ricardo; Faria, Cláudia C.; et al. "CDH3/P-cadherin is a novel oncogenic biomarker with prognostic value in glioblastoma". Paper presented in EACR-AACR-ASPIC Basic and Translational Research Conference, 2020.
  16. Gonçalves, Céline S.; Vieira de Castro, Joana; Xavier-Magalhães, Ana; Martins, Eduarda P.; Pojo, Marta; Queirós, Sandro; Faria, Cláudia C.; et al. "Deciphering WNT6 up and down roads in glioblastoma: mechanistic, functional, and clinical insight". Paper presented in EACR-AACR-ASPIC Basic and Translational Research Conference, 2020.
  17. Brito, Cheila; Luís, Rafael; Cavaco, Daniela; Donato, Sara; Maciel, Joana; Dias, Daniela; Pereira,Teresa; et al. "Efeito da Somatropina em doentes pediátricos com lesão residual de gliomas de baixo grau – Dados in vitro e clínicos". Paper presented in Congresso Português de Endocrinologia 2020 – 71ª Reunião Anual da Sociedade Portuguesa de Endocrinologia, 2020.
  18. Brito, Cheila; Serra, Ana Teresa; Silva,Sandra; Bronze, Maria Rosário; Pojo, Marta. "The effect of olive oil derived compounds in melanoma and melanocytes cells viability". Paper presented in 9th International Conference on Polyphenols and Health (ICPH2019) Kobe, Japan, 2019.
  19. Brito, Cheila; Ferreira, Andreia; Luís, Rafael; Victor, Farricha; Nunes, Hugo; Costa Rosa, Joaninha; Moura, Cecília; Barral C., Duarte; Pojo, Marta. "O impacto das proteínas ADP Ribosylation Factor Like na agressividade do melanoma". Paper presented in 7º Simpósio Nacional de Melanoma, Lagos, 2019.
  20. Martins, Eduarda P.; Pojo, Marta; Gonçalves, Céline S.; Carvalho, Rita; Ribeiro, Ana S.; Taipa, Ricardo; Pardal, Fernando; et al. "Functional and prognostic relevance of CDH3/P-cadherin in glioblastoma". Paper presented in 6th Annual Meeting ISCaM, 2019.
  21. Brito, Cheila; Esteves, Susana; Marques, Ana Rita; Martins, Carmo; Costa, Ilda; Mafra, Manuela; Bravo Marques, José; Roque, Lúcia; Pojo, Marta. "Da Biologia Molecular à Clínica: o papel das alterações moleculares nos genes TERT, PTEN, EGFR e MGMT no diagnóstico, prognóstico e resposta à terapia nos subgrupos moleculares de gliomas.". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, Porto, 2019.
  22. Brito, Cheila; Ana, Azevedo; Tomás, Ana; Esteves, Susana; Martins, Carmo; Mafra, Manuela; Roque, Lúcia; Pojo, Marta. "Análise mutacional do gene PIK3CA nos subgrupos moleculares de gliomas.". Paper presented in Poster session 1º Encontro Nacional de Jovens Investigadores em Oncologia, Porto, 2019.
  23. Brito, Cheila; Azevedo, Ana; Tomás, Ana; Esteves, Susana; Martins, Carmo; Mafra, Manuela; Roque, Lúcia; Pojo, Marta. "Análise mutacional do gene PIK3CA nos subgrupos moleculares de glioma". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, Porto, 2019.
  24. Gonçalves, Céline S.; Vieira de Castro, Joana; Xavier-Magalhães, Ana; Martins, Eduarda P.; Pojo, Marta; Queirós, Sandro; Chautard, Emmanuel; et al. "Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights". Paper presented in Brain Tumor Meeting 2019, 2019.
  25. Martins, Eduarda P.; Pojo, Marta; Gonçalves, Céline C.; Carvalho, Rita; Ribeiro, Ana S.; Taipa, Ricardo; Pardal, Fernando; et al. "CDH3/P-cadherin is an oncogenic biomarker in glioblastoma". Paper presented in 3rd ICVS Open Day, 2019.
  26. Brito, Cheila; Ana, Azevedo; Marques, Ana Rita; Martins, Carmo; Roques, Lúcia; Pojo, Marta. "Clinical Implications of PIK3CA mutations in gliomas molecular subgroups". Paper presented in 3rd ASPIC International Congress, 2018.
  27. Martins, Eduarda P.; Pojo, Marta; Gonçalves, Céline S.; Carvalho, Rita; Ribeiro, Ana S.; Pardal, Fernando; Pinto, Afonso A.; et al. "CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma". Paper presented in 3rd ASPIC International Congress, 2018.
  28. Martins, Eduarda P.; Pojo, Marta; Gonçalves, Céline S.; Carvalho, Rita; Ribeiro, Ana S.; Pardal, Fernando; Pinto, Afonso A.; et al. "CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights". Paper presented in 25th Porto Cancer Meeting, 2018.
  29. Martins, Eduarda P.; Pojo, Marta; Gonçalves, Céline S.; Carvalho, Rita; Ribeiro, Ana S.; Pardal, Fernando; Pinto, Afonso A.; et al. "Functional impact and prognostic relevance of CDH3/P-cadherin in glioblastoma". Paper presented in 2nd ICVS Open Day, 2018.
  30. Martins, Eduarda P.; Pojo, Marta; Ribeiro, Ana S.; Gonçalves, Céline S.; Miranda-Gonçalves, Vera; Taipa, Ricardo; Pardal, Fernando; et al. "CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance". Paper presented in 1st ICVS Open Day, 2017.
  31. Gonçalves, Céline S.; Pojo, Marta; Xavier-Magalhães, Ana; Vieira de Castro, Joana; Miranda-Gonçalves, Vera; Pinto, Afonso A.; Taipa, Ricardo; et al. "WNT6 regulation in Glioblastoma: Mechanistic, Functional and Clinical implications". Paper presented in 1st ICVS Open Day, 2017.
  32. Gonçalves, Céline S.; Pojo, Marta; Xavier-Magalhães, Ana; Vieira de Castro, Joana; Pinto, Afonso A.; Taipa, Ricardo; Pardal, Fernando; et al. "Regulation of WNT6 by HOXA9 in glioblastoma: functional and clinical relevance". Paper presented in 2nd ASPIC International Congress, 2016.
    10.1158/2326-6074.tumimm17-b44
  33. Pojo, Marta; Gonçalves, Céline S.; Xavier-Magalhães, Ana; Fernandes, Ricardo; Gonçalves, Tiago; Rodrigues, Ana J.; Costa, Sandra; et al. "A Transcriptomic Signature Mediated by HOXA9 Sustains Human Glioblastoma Aggressiveness and Resistance to Chemotherapy". Paper presented in II International Symposium on Clinical and Basic Investigation in Glioblastoma, 2015.
  34. Gonçalves, Céline S.; Pojo, Marta; Xavier-Magalhães, Ana; Pinto, Afonso A.; Clara, Carlos; Taipa, Ricardo; Pires, Manuel M.; et al. "HOXA9-mediated activation of the WNT pathway: functional and clinical relevance in glioblastoma". Paper presented in XXIII Porto Cancer Meeting ¿ Stem Cells and Cancer, 2015.
  35. Gonçalves, Céline S.; Pojo, Marta; Xavier-Magalhães, Ana; Pinto, Afonso A.; Clara, Carlos; Pires, Manuel M.; Pinheiro, Célia; et al. "Regulation of Wnt Signaling by HOXA9 in Glioblastoma: Mechanistic and Prognostic Insights". Paper presented in 1st ASPIC International Congress, 2014.
  36. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Lourenço, Tatiana; Pojo, Marta; Lopes, M.C.; Rebelo, O.; Pinto, Afonso A.; et al. "HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma". Paper presented in 1st ASPIC International Congress, 2014.
  37. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Pojo, Marta; Pinto, Afonso A.; Pires, Manuel M.; Pinheiro, Célia; Reis, Rui M.; Sousa, Nuno; Costa, Bruno M.. "WNT6 promoter methylation associates with its expression in glioblastoma". Paper presented in EMBO workshop, Epigenetic plasticity: Implications in neural (dys)function, 2014.
  38. Pojo, Marta; Gonçalves, Céline S.; Xavier-Magalhães, Ana; Oliveira, Ana I.; Gonçalves, Tiago; Rodrigues, Ana J.; Costa, Sandra; et al. "A Transcriptomic Signature Mediated by HOXA9 Sustains Human Glioblastoma Aggressiveness, Resistance to Chemotherapy and Glioma Initiation". Paper presented in VI National Meeting of the Portuguese Association of Neuro-Oncology, 2013.
  39. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Lourenço, Tatiana; Pojo, Marta; Rocha, Miguel; Lopes, Maria C.; Crespo, Inês; et al. "Long Non-Coding RNA HOTAIR is Transcriptionally Activated by HOXA9 and Is Associated with Poor Prognosis in Glioblastoma.". Paper presented in Non-coding RNA, epigenetics and transgenerational inheritance (RNA2013) Meeting, 2013.
  40. Pojo, Marta; Gonçalves, Céline S.; Xavier-Magalhães, Ana; Fernandes, Ricardo; Gonçalves, Tiago; Rodrigues, Ana J.; Costa, Sandra; et al. "HOXA9 Promotes Glioma Initiation and Sustains Human Glioblastoma Aggressiveness and Resistance to Therapy". Paper presented in XXII Porto Cancer Meeting & III Porto-Bordeaux Joint Meeting, 2013.
  41. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Pojo, Marta; Rocha, Miguel; Sousa, Nuno; Costa, Bruno M.. "Regulation of WNT6 expression by HOXA9 in glioblastoma and prognostic implications". Paper presented in 6th National Meeting on Cell Signaling, 2012.
Journal article
  1. José A. Maximino; Alexandra Mayer; António Lourenço; Rui O. Soares; Marta Pojo. "Skin cancer screening: the experience in South Portugal". International Journal of Dermatology (2024):
    Open access • 10.1111/ijd.17065
  2. Hipólito, Ana; Xavier, Renato; Brito, Cheila; Tomás, Ana; Lemos, Isabel; Cabaço, Luís C.; Silva, Fernanda; et al. "BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870 (2024): 166983.
    Open access • 10.1016/j.bbadis.2023.166983
  3. Joana Simões-Pereira; Ana Saramago; Ricardo Rodrigues; Marta Pojo; Carolina Pires; Mariana Horta; Dolores López-Presa; et al. "Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes". Endocrine (2023):
    Open access • 10.1007/s12020-023-03633-y
  4. Ana Teresa Pinto; Marta Pojo; Ricardo Rodrigues; Diana Pacheco Sousa; Rune Matthiesen; Ana Sofia Carvalho; Hans C. Beck; et al. "SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells". Cancers 15 (2023): 4387.
    Open access • 10.3390/cancers15174387
  5. Acúrcio, Rita C.; Pozzi, Sabina; Carreira, Barbara; Pojo, Marta; Gómez-Cebrián, Nuria; Casimiro, Sandra; Fernandes, Adelaide; et al. "Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment". Journal for ImmunoTherapy of Cancer 10 7 (2022): e004695. http://dx.doi.org/10.1136/jitc-2022-004695.
    10.1136/jitc-2022-004695
  6. Martins, Eduarda P.; Gonçalves, Céline S.; Pojo, Marta; Carvalho, Rita; Ribeiro, Ana S.; Miranda-Gonçalves, Vera; Taipa, Ricardo; et al. "Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma". Molecular Oncology 16 14 (2022): 2611-2631. http://dx.doi.org/10.1002/1878-0261.13162.
    10.1002/1878-0261.13162
  7. Cabaço, Luís C.; Tomás, Ana; Pojo, Marta; Barral, Duarte C.. "The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness". Frontiers in Oncology 12 (2022): http://dx.doi.org/10.3389/fonc.2022.887366.
    10.3389/fonc.2022.887366
  8. Lopes, Marta; Vieira de Castro, Joana; Pojo, Marta; Gonçalves, Céline S.; Martins, Eduarda P.; Coimbra, Bárbara; Sotiropoulos, Ioannis; et al. "Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma". Frontiers in Oncology 12 (2022): http://dx.doi.org/10.3389/fonc.2022.856210.
    10.3389/fonc.2022.856210
  9. Brito, Cheila; Tomás, Ana; Azevedo, Ana; Esteves, Susana; Mafra, Manuela; Roque, Lúcia; Pojo, Marta. "PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness". Clinical Medicine Insights: Oncology 16 (2022): 117955492110688. http://dx.doi.org/10.1177/11795549211068804.
    10.1177/11795549211068804
  10. Marques, Inês J.; Gomes, Inês; Pojo, Marta; Pires, Carolina; Moura, Margarida M.; Cabrera, Rafael; Santos, Catarina; et al. "Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer". Thyroid 31 9 (2021): 1366-1375. http://dx.doi.org/10.1089/thy.2020.0290.
    10.1089/thy.2020.0290
  11. Brito, Cheila; Costa-Silva, Bruno; Barral, Duarte C.; Pojo, Marta. "Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis". International Journal of Molecular Sciences 22 17 (2021): 9260. http://dx.doi.org/10.3390/ijms22179260.
    10.3390/ijms22179260
  12. Brito, Cheila; Tomás, Ana; Silva, Sandra; Bronze, Maria Rosário; Serra, Ana Teresa; Pojo, Marta. "The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models". Molecules 26 2 (2021): 289. http://dx.doi.org/10.3390/molecules26020289.
    10.3390/molecules26020289
  13. Brito, Cheila; Barral, Duarte C.; Pojo, Marta. "Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness". Frontiers in Cell and Developmental Biology 8 (2020): http://dx.doi.org/10.3389/fcell.2020.575223.
    10.3389/fcell.2020.575223
  14. Filipa Martins; Luís G. Gonçalves; Marta Pojo; Jacinta Serpa. "Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas". Biomolecules (2020): https://www.mdpi.com/2218-273X/10/10/1370.
    10.3390/biom10101370
  15. Pojo, Marta; Sofia Fargoso; Sidónia Santos; Patricia Machado; Branca Maria Cavaco; Fátima Vaz. "APOL2: A New Candidate Gene Associated with Hereditary Prostate Cancer". British Journal of Cancer Research 3 3 (2020): 401-406. https://makperiodicallibrary.com/britishjournalofcancerresearch/wp-content/uploads/2020/04/BJCR-152.pdf.
    Open access • Published
  16. Campos, Catarina; Fragoso, Sofia; Luís, Rafael; Pinto, Filipe; Brito, Cheila; Esteves, Susana; Pataco, Margarida; et al. "High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma". Genes 11 4 (2020): 403. http://dx.doi.org/10.3390/genes11040403.
    Published • 10.3390/genes11040403
  17. Brito, Cheila; Azevedo, Ana; Esteves, Susana; Marques, Ana Rita; Martins, Carmo; Costa, Ilda; Mafra, Manuela; et al. "Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation". BMC Cancer 19 1 (2019): http://dx.doi.org/10.1186/s12885-019-6177-0.
    10.1186/s12885-019-6177-0
  18. Pinto, Ana T.; Pojo, Marta; Simões-Pereira, Joana; Roque, Ruben; Saramago, Ana; Roque, Lúcia; Martins, Carmo; et al. "Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology". Endocrine 66 2 (2019): 288-300. http://dx.doi.org/10.1007/s12020-019-02009-5.
    10.1007/s12020-019-02009-5
  19. Sousa, Diana P.; Pojo, Marta; Pinto, Ana T.; Leite, Valeriano; Serra, Ana Teresa; Cavaco, Branca M.. "Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines". Nutrition and Cancer 72 2 (2019): 352-363. http://dx.doi.org/10.1080/01635581.2019.1634745.
    10.1080/01635581.2019.1634745
  20. Lopes-Ventura, S.; Pojo, M.; Matias, A. T.; Moura, M. M.; Marques, I. J.; Leite, V.; Cavaco, B. M.. "The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines". Journal of Endocrinological Investigation 42 5 (2018): 527-540. http://dx.doi.org/10.1007/s40618-018-0947-4.
    10.1007/s40618-018-0947-4
  21. Xavier-Magalhães, Ana; Gonçalves, Céline S.; Fogli, Anne; Lourenço, Tatiana; Pojo, Marta; Pereira, Bruno; Rocha, Miguel; et al. "The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma". Oncotarget 9 21 (2018): http://dx.doi.org/10.18632/oncotarget.24597.
    10.18632/oncotarget.24597
  22. Gonçalves, Céline S.; de Castro, Joana Vieira; Pojo, Marta; Martins, Eduarda P.; Queirós, Sandro; Chautard, Emmanuel; Taipa, Ricardo; et al. "WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma". Theranostics 8 17 (2018): 4805-4823. http://dx.doi.org/10.7150/thno.25025.
    10.7150/thno.25025
  23. Xavier-Magalhães, Ana; Oliveira, Ana I.; de Castro, Joana Vieira; Pojo, Marta; Gonçalves, Céline S.; Lourenço, Tatiana; Viana-Pereira, Marta; et al. "Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis". Journal of Neuro-Oncology 132 1 (2017): 27-34. http://dx.doi.org/10.1007/s11060-016-2345-0.
    10.1007/s11060-016-2345-0
  24. Miranda-Gonçalves, V.; Granja, S.; Martinho, O.; Honavar, M.; Pojo, M.; Costa, B.M.; Pires, M.M.; et al. "Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas". Oncotarget 7 29 (2016): 46335-46353. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979950555&partnerID=MN8TOARS.
    10.18632/oncotarget.10114
  25. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Pojo, Marta; Oliveira, Ana Isabel; Correia, Sara; Reis, Rui M.; Sousa, Nuno; Rocha, Miguel; Costa, Bruno M.. "Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models". Genomics Data 5 (2015): 54-58. http://dx.doi.org/10.1016/j.gdata.2015.05.010.
    10.1016/j.gdata.2015.05.010
  26. Gonçalves, Céline S.; Xavier-Magalhães, Ana; Pojo, Marta; Oliveira, Ana Isabel; Correia, Sara; Reis, Rui M.; Sousa, Nuno; Rocha, Miguel; Costa, Bruno M.. "Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models". Genomics Data 5 (2015): 54-58. http://dx.doi.org/10.1016/j.gdata.2015.05.010.
    10.1016/j.gdata.2015.05.010
  27. Pojo, M.; Gonçalves, C.S.; Xavier-Magalhães, A.; Oliveira, A.I.; Gonçalves, T.; Correia, S.; Rodrigues, A.J.; et al. "A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide". Oncotarget 6 10 (2015): 7657-7674. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928404326&partnerID=MN8TOARS.
    10.18632/oncotarget.3150
  28. Pojo, M.; Cerqueira, S. R.; Mota, T.; Xavier-Magalhães, A.; Ribeiro-Samy, S.; Mano, J. F.; Oliveira, J. M.; et al. "In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models". Journal of Nanoparticle Research 15 5 (2013): http://dx.doi.org/10.1007/s11051-013-1621-6.
    10.1007/s11051-013-1621-6
Thesis / Dissertation
  1. Sousa, Marta Sofia Pojo. "HOXA9 as a key regulator in glioma initiation, aggressiveness and response to therapy". PhD, 2016. http://hdl.handle.net/1822/40788.
  2. Sousa, Marta Sofia Pojo. "Compostos naturais extraídos de plantas na protecção do stresse oxidativo em modelos celulares de músculo". Master, 2010. http://hdl.handle.net/1822/19691.

Intellectual property

Patent
  1. Serpa, Jacinta; FILIPA AlexALEXANDRA DIAS MARTINS; DAVID ALEXANDRE DIAS VAN-DER KELLEN; FERNANDA MARIA GONÇALVES DA SILVA; SOFIA GOUVEIA PEREIRA FERNANDES; Gonçalves, Luís G; Pojo, Marta; et al. 2023. "GLUTAMINASE, METHODS AND USES THEREOF". Portugal.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2020/02/28 The mechanisms of melanoma aggressiveness: functional and clinical implications Melanoma e Genómica
Instituto Português de Oncologia de Lisboa Francisco Gentil (Lisboa, Portugal)
2019/11/21 The effect of somatropine treatment on cell proliferation using pediatric gliomas cell models Reunião Anual da Sociedade Portuguesa de Endocrinologia e Diabetologia Pediatrica
Sociedade Portuguesa de Endocrinologia e Diabetologia Pediatrica (Coimbra, Portugal)
2019/10/27 Genética e Melanoma – da Investigação à Clínica 7º Simpósio Nacional de Melanoma
Intergrupo Português de Melanoma (Lagos, Portugal)
2019/09/24 Biomarkers in Tumorigenesis: Initiation, progression and response to therapy I Encontro Nacional de Jovens Investigadores em Oncologia
Liga Portuguesa Contra o Cancro – Núcleo Regional do Norte (Porto, Portugal)
2019/07/24 The mechanisms of melanoma aggressiveness: functional and clinical implications CEDOC Seminars
CEDOC, NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa (Lisboa, Portugal)
2019/04/17 Initiation and Progression of Cutaneous Melanoma BIOSAM – Biological Sciences Annual Meeting
Faculdade de Ciências da Universidade de Lisboa (Lisboa, Portugal)
2019/03/28 Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation Seminaries UIPM
UIPM - Instituto Português de Oncologia de Lisboa Francisco Gentil (Lisboa, Portugal)
2018/05/17 Rare germline variant identified in familial prostate cancer 8th ESO-CNIO Conference on Familial Cancer
ESO-CNIO (Madrid, Spain)
2018/02/03 Bolsas de Investigação: Como concorrer e onde pesquisar Fórum do interno e do jovem especialista - 69ª Reunião Anual da SPEDM
Sociedade Portuguesa De Endocrinologia Diabetes E Metabolismo (Albufeira , Portugal)
2017/11/23 Germinal mutations in melanoma 5.º Simpósio Nacional de Melanoma
Intergrupo Português de Melanoma (Batalha, Portugal)
2015/12/12 CDH3/P-cadherin is a HOXA9 target in glioma, associated with tumor aggressiveness and prognosis of glioblastoma patient Congresso Nacional de Neuro Oncologia
Associação Portuguesa de Neuro-Oncologia (Lisboa, Portugal)
2014/11/25 HOXA9 Promotes Glioblastoma Initiation, Aggressiveness and Resistance to Therapy 1st ASPIC International Congress
Associação Portuguesa de Investigação em Cancro (Lisboa, Portugal)
2014/11/22 Relevância do oncogene HOXA9 em Glioblastoma: efeitos na iniciação tumoral, agressividade, e resistência à temozolamida VII Congresso Nacional de Neuro Oncologia
Associação Portuguesa de Neuro-Oncologia (Lisboa, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2019/09/01 - Current Development of an in vitro full humanised reconstructed 3D human melanoma skin model with peripheral blood mononuclear cell (PBMC)
Supervisor of Mafalda Leite
 Master Biochemistry for Health (Master)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
2019/09/01 - Current Targeted inhibition of PIK3CA mutations in glioblastoma cell models
Supervisor of Ana Tomás
 Mestrado em Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2020/01/06 - 2020/07/30 The functional role of BRD9 in cutaneous melanoma
Supervisor
 Biologia (Degree)
Universidade de Aveiro, Portugal
2018/09/01 - 2019/12/03 Study of genes and pathways involved in familial thyroid cancer etiology
Co-supervisor of Carolina Pires
 Mestrado em Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2017/09/01 - 2019/03/01 Molecular characterization of novel candidate genes for familial melanoma susceptibility
Supervisor
 Mestrado em Biologia Molecular e Genética (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
2017/09/01 - 2018/11/18 Clinical implications of PIK3CA mutation in low and high-grade gliomas
Supervisor
 Mestrado em Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2018/01/06 - 2018/05/23 Identification of new potential pathogenic variants genes in families with history of melanoma cancer
Supervisor
 Biologia Celular e Molecular (Degree)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2020/01/28 - Current Segundas de Conversas - são palestras informais com o objectivo de procurar esclarecer a comunidade sobre várias temáticas no âmbito da oncologia, estimulando a melhoria da literacia em saúde. Promover a discussão informal e participada sobre dúvidas que surjam ao abordar os vários temas relacionados com o cancro. (2020/01/28)
Seminar (Co-organisor)
 Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal
2020/10/15 - 2021/10/30 The conference «Cutaneous Melanoma: from where to Where?» brought together some of the most prestigious researchers in the field. The most promising results of ¿¿the cutaneous melanoma investigation were presented at this meeting with a live broadcast from Lisbon to the world. Several subjects of tumor complexity were discussed: diagnosis, the contribution of Artificial Intelligence, new biomarkers, treatment, immunotherapy, and new therapeutic approaches. The conference also included clinical cases discussion. (2021/10/15 - 2021/10/15)
Conference (Member of the Organising Committee)
 Liga Portuguesa Contra o Cancro, Portugal
2019/06/20 - 2020/09/30 "Cancer Biology: From Basic To Translational Research” conference joined national and international researchers in basic and clinical oncology to present the most promising results that might have a clinical impact in the oncology field. Different thematics of tumor complexity (genetics, biomarkers, tumor microenvironment, tumor metabolism, and new potential therapeutic targets) were addressed, and the application of knowledge to improve the diagnosis or treatments of cancer patients. (2020/09/25 - 2020/09/25)
Conference (Member of the Scientific Committee)
 Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal
2017/05/01 - 2017/09/22 Conferência de Risco Familiar de Cancro - visa reunir os investigadores nacionais e internacionais a desenvolver investigação na area de risco familiar de cancro. (2017/09/22)
Conference (Member of the Organising Committee)
 Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal
2016/04/01 - 2017/04/28 Conference “Immunology & Cancer" - debate do estado actual da imuno-oncologia e progresso das imunoterapias. (2017/04/28 - 2017/04/28)
Conference (Member of the Organising Committee)
 Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
2007/01/01 - 2007/06/08 Comemoração do 10º Aniversário da Licenciatura em Biologia Aplicada na Universidade do Minho - visou fazer um ponto de situação do curso, as oportunidades e desafios gerados pelos 10 primeiros anos. Contou com a participação de alunos de todas as edições do curso. (2007/06/04 - 2007/06/08)
Meeting (Member of the Organising Committee)
 Universidade do Minho, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2023/03/13 Modulating membrane traffic regulators to impair breast cancer progression
(Thesis) Arguer
 Andreia Ferreira Teixeira (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/01/26 Unveiling the clinical relevance of low-density neutrophils in Breast Cancer patients
(Thesis) Main arguer
 Bruna Filipa Campos Correia (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2021/01/11 Modulating membrane traffic regulators to impair breast cancer progression
(Thesis) Main arguer
 Diana Catarina De Sousa Coito (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2020/07/06 Lactate and glucose metabolism in lung carcinoma - in vitro study
(Thesis) Main arguer
 Mara Santiago Rodrigues (Other)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2019/10/29 Cysteine Metabolism and Pancreatic Neuroendocrine Tumours (PNETs) Chemoresistance
(Thesis) Main arguer
 Rakhi Chanda Roy (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/05/06 Deciphering the pathways leading to the enhancement of NIS transcription in thyroid tissue
(Thesis) Main arguer
 Francisca Ventura Paixão (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal

Association member

Society Organization name Role
2006/11/01 - 2007/11/01 Núcleo de Estudantes de Biologia Aplicada Presidente

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2020/10/23 - Current CURSO PÓS-GRADUADO EM GENETICA E GENÓMICA PARA CLÍNICOS CURSO PÓS-GRADUADO EM GENETICA E GENÓMICA PARA CLÍNICOS (Postgraduate Certificate) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/03/09 - Current Aula: Vias de transdução de sinal em cancro na cadeira Biologia Molecular e Celular do Cancro (when cells break the rules and highjack their own planet) Mestrado Em Biologia Evolutiva e do Desenvolvimento (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2019/03/22 - Current Epigenetic Biomarkers in Diagnosis curso Epigenética e Cancro do Programa Doutoral em Medicina da Nova Medical School (Curso de doutoramento (conclusão de unidades curriculares)) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/05/13 - 2019/05/17 Carcinogenesis – underlying molecular and cellular alterations NBR - NOVA BIOMEDICAL RESEARCH (Master) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018/05/21 - 2018/05/31 Carcinogenesis – underlying molecular and cellular alterations NBR - NOVA Biomedical Research Master NBR - NOVA Biomedical Research Master (Master) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Interview (newspaper / magazine)

Activity description Newspaper / Forum
2020/03/27 Entrevista sobre o trabalho desenvolvido no âmbito de cancro familiar. Foi também abordado o meu percurso cientifico. Notícias de Fafe

Interview (tv / radio show)

Program Topic
2020/03/04 - Current Reportagem televisão Cancro familiar
2017/08/07 - 2017/08/07 Ciência e Saúde Cancro de Pele

Journal scientific committee

Journal title (ISSN) Publisher
2020/01/31 - Current Metabolites (2218-1989) MDPI AG
2019/09/30 - Current Journal of Clinical Medicine (2077-0383) MDPI
2019/02/13 - Current Cancers (2072-6694) MDPI
Distinctions

Award

2020 MELHOR TRABALHO DE INVESTIGAÇÃO BÁSICA
Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo , Portugal
2019 Melhor trabalho de investigação Básica/Clínica
Sociedade Portuguesa de Endocrinologia e Diabetologia Pediatrica, Portugal
2018 Melhor poster
Associação Portugesa de Investigação em Cancro , Portugal
2014 Melhor comunicação oral
Associação Portuguesa de Neuro-Oncologia , Portugal
2013 Melhor apresentação de Poster
XXII Porto Cancer Meeting & III Porto-Bordeaux Joint Meeting., Portugal
2013 Prémio de melhor poster
Associação Portuguesa de Neuro-Oncologia , Portugal

Other distinction

2015 EACR Participation Grant
European Association For Cancer Research, United Kingdom
2013 EACR meeting bursary
European Association For Cancer Research, United Kingdom